$LVWR
LiveWire Group, Inc.

2023 Q3 Form 10-Q Financial Statement

#000189879523000100 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $8.144M $7.026M $0.00
YoY Change 117.27%
Cost Of Revenue $7.052M $9.966M $12.90M
YoY Change -48.69% -22.72% 22.24%
Gross Profit $1.092M -$2.940M -$12.90M
YoY Change -110.93% -77.2% 992.88%
Gross Profit Margin 13.41% -41.84%
Selling, General & Admin $26.44M $29.04M $18.97M
YoY Change 20.22% 53.14% 4347.83%
% of Gross Profit 2420.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.440M $700.0K $1.350M
YoY Change -61.26% -48.15% 29.81%
% of Gross Profit 131.87%
Operating Expenses $26.44M $29.04M $676.1K
YoY Change 685.04% 4196.13% 58.54%
Operating Profit -$25.34M -$31.98M -$19.36M
YoY Change 652.61% 65.24% 1104.92%
Interest Expense $2.730M $2.750M $261.0K
YoY Change -91100.0% 953.72% 2177.31%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $12.51M
YoY Change -100.0% -100.0% -783.33%
Pretax Income -$14.58M -$40.67M $12.09M
YoY Change -30.4% -436.38% -638.54%
Income Tax -$1.000K $64.00K $95.00K
% Of Pretax Income 0.79%
Net Earnings -$14.58M -$40.73M $12.09M
YoY Change -474.54% -436.91% -638.54%
Net Earnings / Revenue -179.0% -579.73%
Basic Earnings Per Share -$0.07 -$0.20 -$0.12
Diluted Earnings Per Share -$0.07 -$0.20 $241.8K
COMMON SHARES
Basic Shares Outstanding 202.5M shares 202.4M shares 161.0M shares
Diluted Shares Outstanding 202.5M shares 202.4M shares 161.0M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $199.9M $215.9M $337.1K
YoY Change 9120.48% 63940.58% -72.59%
Cash & Equivalents $199.9M $215.9M $5.365M
Short-Term Investments
Other Short-Term Assets $1.946M $2.720M $131.8K
YoY Change -98.07% 1963.26% -70.39%
Inventory $32.79M $32.17M $27.52M
Prepaid Expenses
Receivables $5.200M $5.100M $3.681M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $239.9M $255.9M $469.0K
YoY Change 70.76% 54456.89% -72.01%
LONG-TERM ASSETS
Property, Plant & Equipment $37.69M $35.68M $23.07M
YoY Change 42.27% 54.68%
Goodwill $8.327M $8.327M
YoY Change
Intangibles $1.463M $1.578M
YoY Change
Long-Term Investments $400.6M
YoY Change 0.1%
Other Assets $6.319M $6.490M $1.300M
YoY Change 109.86% 399.23%
Total Long-Term Assets $56.02M $54.61M $400.6M
YoY Change -78.63% -86.37% 0.1%
TOTAL ASSETS
Total Short-Term Assets $239.9M $255.9M $469.0K
Total Long-Term Assets $56.02M $54.61M $400.6M
Total Assets $295.9M $310.5M $401.0M
YoY Change -26.5% -22.59% -0.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.50M $22.40M $8.308M
YoY Change 44.69% 169.62%
Accrued Expenses $18.49M $17.05M $14.14M
YoY Change 21.38% 20.58% 5028.05%
Deferred Revenue $428.0K $206.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $45.40M $40.83M $19.90M
YoY Change -66.11% 105.19% -32.68%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $397.0K $425.0K $13.13M
YoY Change -92.6% -96.76% 0.0%
Total Long-Term Liabilities $397.0K $425.0K $13.13M
YoY Change -92.6% -96.76% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $45.40M $40.83M $19.90M
Total Long-Term Liabilities $397.0K $425.0K $13.13M
Total Liabilities $57.41M $61.33M $33.02M
YoY Change -85.73% 85.72% -22.63%
SHAREHOLDERS EQUITY
Retained Earnings -$98.90M -$84.32M
YoY Change 224.72%
Common Stock $20.00K $20.00K
YoY Change 1654.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $238.5M $249.1M -$32.55M
YoY Change
Total Liabilities & Shareholders Equity $295.9M $310.5M $401.0M
YoY Change -26.5% -22.59% -0.2%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$14.58M -$40.73M $12.09M
YoY Change -474.54% -436.91% -638.54%
Depreciation, Depletion And Amortization $1.440M $700.0K $1.350M
YoY Change -61.26% -48.15% 29.81%
Cash From Operating Activities -$14.68M -$16.65M -$219.7K
YoY Change -76.88% 7478.86% -49.03%
INVESTING ACTIVITIES
Capital Expenditures $2.790M $3.530M $3.230M
YoY Change -68.75% 9.29% 164.75%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.790M -$3.530M -$3.230M
YoY Change -68.75% 9.29% 164.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.550M 0.000 15.34M
YoY Change -99.1% -100.0% 7.27%
NET CHANGE
Cash From Operating Activities -14.68M -16.65M -219.7K
Cash From Investing Activities -2.790M -3.530M -3.230M
Cash From Financing Activities 1.550M 0.000 15.34M
Net Change In Cash -15.92M -20.18M -219.7K
YoY Change -115.89% 9085.67% -49.03%
FREE CASH FLOW
Cash From Operating Activities -$14.68M -$16.65M -$219.7K
Capital Expenditures $2.790M $3.530M $3.230M
Free Cash Flow -$17.47M -$20.18M -$3.450M
YoY Change -75.88% 484.98% 108.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
LVWR
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
249129000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
306800000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
310461000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
351805000 usd
us-gaap Net Income Loss
NetIncomeLoss
-61879000 usd
us-gaap Net Income Loss
NetIncomeLoss
-35557000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1372000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2806000 usd
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
0 usd
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
413000 usd
lvwr Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-10370000 usd
lvwr Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4202000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
-171000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
55000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
27000 usd
lvwr Deferred Income Tax Expense Benefit Net Of Reverse Capitalization Adjustments
DeferredIncomeTaxExpenseBenefitNetOfReverseCapitalizationAdjustments
63000 usd
lvwr Deferred Income Tax Expense Benefit Net Of Reverse Capitalization Adjustments
DeferredIncomeTaxExpenseBenefitNetOfReverseCapitalizationAdjustments
82000 usd
us-gaap Inventory Write Down
InventoryWriteDown
1626000 usd
us-gaap Inventory Write Down
InventoryWriteDown
597000 usd
lvwr Capitalization Of Cloud Computing Arrangements
CapitalizationOfCloudComputingArrangements
640000 usd
lvwr Capitalization Of Cloud Computing Arrangements
CapitalizationOfCloudComputingArrangements
1158000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
629000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
511000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2407000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3064000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-118000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
1124000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4585000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11321000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1905000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1892000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1357000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4143000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
10591000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-41195000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37644000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8175000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5722000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8175000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5722000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
15333000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1767000 usd
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 usd
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
32497000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46063000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-49368000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2697000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
265240000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2668000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
306800000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21147000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1824000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
287477000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-40732000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2378000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
249129000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19925000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-15979000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-100000 usd
CY2022Q1 lvwr Net Contributions From Parent
NetContributionsFromParent
19051000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
22897000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19578000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000 usd
CY2022Q2 lvwr Net Contributions From Parent
NetContributionsFromParent
34060000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2022Q3 lvwr Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
1
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
161000000 shares
CY2022Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
200000000 usd
CY2022Q3 lvwr Proceeds From Reverse Capitalization Transaction
ProceedsFromReverseCapitalizationTransaction
293700000 usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
202402888 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
202402888 shares
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7026000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12506000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14788000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22907000 usd
lvwr Variable Consideration Related To Previously Recognized Sales
VariableConsiderationRelatedToPreviouslyRecognizedSales
250000 usd
CY2023Q2 lvwr Variable Consideration Related To Previously Recognized Sales
VariableConsiderationRelatedToPreviouslyRecognizedSales
250000 usd
lvwr Variable Consideration Related To Previously Recognized Sales
VariableConsiderationRelatedToPreviouslyRecognizedSales
0 usd
CY2022Q2 lvwr Variable Consideration Related To Previously Recognized Sales
VariableConsiderationRelatedToPreviouslyRecognizedSales
0 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
206000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
163000 usd
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
85000 usd
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
895000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
163000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2185000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
206000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.005
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-40732000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-19578000 usd
us-gaap Net Income Loss
NetIncomeLoss
-61879000 usd
us-gaap Net Income Loss
NetIncomeLoss
-35557000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
202409000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
202407000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161000000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
202409000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
202407000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161000000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
161000000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42182000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
47502000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1095000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
105000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
95000 usd
CY2023Q2 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
2793000 usd
CY2022Q4 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
48000 usd
CY2023Q2 lvwr Inventory Parts And Accessories And Apparel Net Of Reserves
InventoryPartsAndAccessoriesAndApparelNetOfReserves
3231000 usd
CY2022Q4 lvwr Inventory Parts And Accessories And Apparel Net Of Reserves
InventoryPartsAndAccessoriesAndApparelNetOfReserves
3876000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
32174000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
29215000 usd
CY2023Q2 lvwr Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
4825000 usd
CY2023Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4428000 usd
CY2023Q2 lvwr Accrued Engineering Current
AccruedEngineeringCurrent
3759000 usd
CY2022Q4 lvwr Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
7748000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4641000 usd
CY2022Q4 lvwr Accrued Engineering Current
AccruedEngineeringCurrent
4377000 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
30499990 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2023Q2 lvwr Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-11438000 usd
lvwr Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-10370000 usd
CY2023Q2 lvwr Warrant Liabilities
WarrantLiabilities
18757000 usd
CY2022Q4 lvwr Warrant Liabilities
WarrantLiabilities
8388000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
566000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
106000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
342000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
0 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-27000 usd
us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
0 usd
us-gaap Standard Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardProductWarrantyAccrualForeignCurrencyTranslationGainLoss
-43000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
0 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
16000 usd
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-3000 usd
us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
124000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
562000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
929000 usd
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
562000 usd
CY2022Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
929000 usd
CY2022Q2 us-gaap Manufacturing Costs
ManufacturingCosts
1945000 usd
us-gaap Manufacturing Costs
ManufacturingCosts
2808000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1417000 usd
us-gaap Operating Expenses
OperatingExpenses
1707000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-31984000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19356000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-56891000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-35055000 usd
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001898795-23-000100-index-headers.html Edgar Link pending
0001898795-23-000100-index.html Edgar Link pending
0001898795-23-000100.txt Edgar Link pending
0001898795-23-000100-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lvwr-20230630.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lvwr-20230630.xsd Edgar Link pending
lvwr-20230630_g1.jpg Edgar Link pending
lvwrexhibit3116-30x2023.htm Edgar Link pending
lvwrexhibit3126-30x2023.htm Edgar Link pending
lvwrexhibit3216-30x2023.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
lvwr-20230630_cal.xml Edgar Link unprocessable
lvwr-20230630_lab.xml Edgar Link unprocessable
lvwr-20230630_pre.xml Edgar Link unprocessable
lvwr-20230630_htm.xml Edgar Link completed
Show.js Edgar Link pending
lvwr-20230630_def.xml Edgar Link unprocessable